Skip to content
Abierto

Special notice

Inbios Reagents

96463

Centers for Disease Control and Prevention, CDC Office of Acquisition Services. In-Vitro Diagnostic Substance Manufacturing.

Response deadline

March 27, 2026 at 5:00 PM EDT

Closed 175 days ago. Posted March 23, 2026. Scheduled to archive March 27, 2026.

Description

As published on SAM.gov.

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to InBios International, Inc. for InBios DENV Detect TM IgM Capture Elisa Kit. The InBios DENV Detect TM IgM Capture Elisa Kit is the only serology test approved by the FDA for dengue diagnosis. This test is performed as part of the ongoing DENV surveillance program at the Dengue Branch Diagnostic Laboratory.

This contract action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of Revolutionary FAR Overhaul 6.103-1 (SAP). This notice of intent is not a request for competitive quotations; however, all quotations/responses received within 15 days of the issuance of this notice shall be considered by the government.

A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at email qsx8@cdc.gov by March 27, 2026 before 5pm EST.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. March 23, 2026

    Special notice

    Due March 27, 2026 at 5:00 PM EDT. SAM.gov, notice 0fe173bba2584460ae311cb8190cab13

Points of contact